Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Melanoma 30Carcinoma, Renal Cell 11Neoplasms 6Neoplasm Metastasis 6Recurrence 4Multiple Myeloma 4Carcinoma, Hepatocellular 4Leukemia 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroendocrine Tumors 2Mycosis Fungoides 2Lymphoma, Follicular 2Lymphoma 2Liver Neoplasms 2Kidney Neoplasms 2Hematologic Neoplasms 2Breast Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Cutaneous 1

Interventions

aldesleukin 42Sunitinib 39Cyclophosphamide 30Nivolumab 27Everolimus 27pembrolizumab 26Interferon-alpha 25Bevacizumab 22Sorafenib 21Interleukin-2 20fludarabine phosphate 19Filgrastim 18Ipilimumab 17Radiotherapy 16Axitinib 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14fludarabine 11Radiosurgery 11Doxorubicin 11Carboplatin 11temsirolimus 10Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8belzutifan 8atezolizumab 8Fluorouracil 8pazopanib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Kidney Neoplasms × Introns × Clear all
NCT00445523 2016-03-17

Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer

The Methodist Hospital Research Institute

Phase 2 Completed
28 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00293527 2013-05-23

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

Ohio State University Comprehensive Cancer Center

Phase 2 Withdrawn
Genitourinary

Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡